Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease

Citation
L. Rossi et al., Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease, BIOT APP B, 33, 2001, pp. 85-89
Citations number
15
Categorie Soggetti
Biotecnology & Applied Microbiology","Biochemistry & Biophysics
Journal title
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
ISSN journal
08854513 → ACNP
Volume
33
Year of publication
2001
Part
2
Pages
85 - 89
Database
ISI
SICI code
0885-4513(200104)33:<85:EDODIP>2.0.ZU;2-M
Abstract
Human erythrocytes from ten patients with chronic obstructive pulmonary dis ease (COPD) were loaded with increasing amounts of dexamethasone 21-phospha te and were re-infused into the original donors. Drug-loaded erythrocytes a cted as circulating bioreactors, converting the non-diffusible dexamethason e 21-phosphate into the diffusible dexamethasone. Pharmacokinetic analyses on these patients showed that a single administration of drug-loaded erythr ocytes was able to maintain detectable dexamethasone concentrations in bloo d for up to seven days. This continuous release of dexamethasone was parall eled by the suspension of beta (2)-agonist and oral corticosteroid treatmen ts by all of the patients,Thus dexamethasone 21-phosphate-loaded erythrocyt es are safe carriers for corticosteroid analogues and are a useful alternat ive to frequent oral or inhaled drugs in elderly patients with COPD.